Korro Bio, Inc. financial data

Symbol
KRRO on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 760% % -32%
Return On Equity -69% % -37%
Return On Assets -46% % -19%
Operating Margin -1282% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9,417,295 shares 0.52%
Common Stock, Shares, Outstanding 9,397,984 shares 0.86%
Entity Public Float $236,755,297 USD 1849%
Common Stock, Value, Issued $9,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 9,391,559 shares 0.95%
Weighted Average Number of Shares Outstanding, Diluted 9,391,559 shares 0.95%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $7,371,000 USD
Research and Development Expense $71,552,000 USD 15%
General and Administrative Expense $30,318,000 USD -9.9%
Operating Income (Loss) $94,499,000 USD 1.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $88,313,000 USD -0.62%
Income Tax Expense (Benefit) $104,000 USD 174%
Net Income (Loss) Attributable to Parent $88,417,000 USD -0.69%
Earnings Per Share, Basic -9 USD/shares -107%
Earnings Per Share, Diluted -9 USD/shares -107%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $24,155,000 USD -62%
Marketable Securities, Current $68,324,000 USD -7.4%
Assets, Current $98,226,000 USD -36%
Property, Plant and Equipment, Net $24,398,000 USD -16%
Operating Lease, Right-of-Use Asset $23,332,000 USD -2.9%
Other Assets, Noncurrent $3,171,000 USD 50%
Assets $161,550,000 USD -34%
Accounts Payable, Current $2,300,000 USD -61%
Accrued Liabilities, Current $5,861,000 USD 7.4%
Liabilities, Current $14,638,000 USD 7.6%
Operating Lease, Liability, Noncurrent $41,523,000 USD -0.63%
Other Liabilities, Noncurrent $1,532,000 USD 114%
Liabilities $62,518,000 USD -2.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $214,000 USD -63%
Retained Earnings (Accumulated Deficit) $333,804,000 USD -36%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $99,032,000 USD -45%
Liabilities and Equity $161,550,000 USD -34%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $24,452,000 USD -12%
Net Cash Provided by (Used in) Financing Activities $172,000 USD 24%
Net Cash Provided by (Used in) Investing Activities $32,781,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 9,397,984 shares 0.86%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,501,000 USD
Deferred Tax Assets, Valuation Allowance $168,319,000 USD 15%
Deferred Tax Assets, Gross $178,651,000 USD 16%
Operating Lease, Liability $44,668,000 USD 6.9%
Depreciation $4,864,000 USD 14%
Payments to Acquire Property, Plant, and Equipment $119,000 USD -98%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $88,777,000 USD -1.5%
Lessee, Operating Lease, Liability, to be Paid $69,790,000 USD -2.9%
Property, Plant and Equipment, Gross $35,357,000 USD -9.3%
Operating Lease, Liability, Current $3,145,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,557,000 USD 2.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,341,000 USD 18%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $25,122,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,778,000 USD 2.9%
Deferred Tax Assets, Operating Loss Carryforwards $94,196,000 USD 17%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,007,000 USD
Additional Paid in Capital $432,613,000 USD 1.9%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $10,332,000 USD 34%
Share-based Payment Arrangement, Expense $6,941,000 USD 60%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%